Barely Significant
← all excerpts

Multimodality Treatment in Metastatic Gastric Cancer: From Past to Next Future.

Cancers (Basel) · 2020 · PMC7563615 · PMID 32932914

Europe PMCDOI
1
hedged sentence
0.0460
closest p · 0.9× alpha
0.0460
boldest claim

The sentences

a favorable trendp = 0.046actually significant
On the other hand, chemotherapy plus pembrolizumab was not formally superior to chemotherapy alone in terms of OS even if a favorable trend was seen both in CPS ≥ 1% (mOS 12.5 vs. 11.1 months, HR: 0.85, p = 0.046) and CPS ≥ 10% (mOS 12.3 vs. 10.8, HR: 0.85, p = 0.158) patients.

also in 1,335 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.